Community Pharmacy Fairness Act of 2009

H.R. 1204, Community Pharmacy Fairness Act (Weiner) antitrust exemption for pharmacies; (cont.) H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; H.R. 3590, Patient Protection and Affordable Care Act (Reid) generic biologics; H.R. 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch); H.R. 4899, Supplemental Appropriations Act (Obey) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 1630, Affordable Access to Prescription Medications Act (Rockefeller) prescription drug co-pays and formularies; and S. 3677, Financial Services and General Government Appropriations Act (Durbin) generic drugs. PHA (Regulatory): Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; and issues relating to access for investigational drugs.

Client expense: $1,980,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

Antitrust - Issues relating to a proposed anti-trust exemption for certain pharmacies and healthcare competition. HR 1204 - Community Pharmacy Fairness Act of 2009

Client expense: $2,189,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Community Pharmacy Fairness Act of 2009 H.R. 1204 Healthy Americans Act H.R. 1321 Emergency Retiree Health Benefits Protection Act H.R. 1322 Family Leave Insurance Act of 2009 H.R. 1723 Long-Term Care Affordability and Security Act of 2009 H.R. 2096 Healthy Families Act H.R. 2460 The Patients Choice Act H.R. 2520 Tax Equity for Health Plan Beneficiaries Act of 2009 H.R. 2625 Prevent application of ERISA preemption to state law causes of action - H.R. 3925 Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 -H.R. 3962/Public Law No: 111-192 Common Sense Health Care Reform and Affordability Act H.R. 4038 American Workers, State, and Business Relief Act H.R. 4213, Unemployment Compensation Extension Act of 2010 Public Law No: 111-205 Medicare and Medicaid Extenders Act H.R. 4994 Health Care Reform regulatory implementation and compliance issues from the Patient Protection and Affordable Care Act (PPACA) Public Law No: 111-148 & the Health Care and Education Reconciliation Act of 2010 (HCERA) Public Law No: 111-152 National Commission on Fiscal Responsibility and Reform implications for benefits Senate Healthy Americans Act - S. 391 Long-Term Care Affordability and Security Act of 2009 S. 702 The Patients Choice Act S. 1099 Healthy Families Act S. 1152 Tax Equity for Health Plan Beneficiaries Act of 2009 S. 1153 Confidence in Long-Term Care Insurance Act S. 1177 Patient Centered Outcomes Research Act S. 1213 American Jobs Protection Act S. 3501 American Workers, State, and Business Relief Act H.R. 4213 & substitute amendment Small Business Paperwork Relief Act S. 3946 Empowering States to Innovate Act S. 3958 Medicare and Medicaid Extenders Act H.R. 4994 Health Care Reform regulatory implementation and compliance issues from the Patient Protection and Affordable Care Act (PPACA) Public Law No: 111-148 & the Health Care and Education Reconciliation Act of 2010 (HCERA) Public Law 111-152 National Commission on Fiscal Responsibility and Reform implications for benefits Regulatory Proposed rule on application of ERISA to state/local health reform efforts COBRA premium subsidy assistance extension American Recovery and Reinvestment Act of 2009 (ARRA) included in the Department of Defense Appropriations Act of 2010 Guidance for and implementation of the Patient Protection and Affordable Care Act (PPACA) & the Health Care and Education Reconciliation Act of 2010 (HCERA) employer responsibility provisions, tax treatment of certain plans, transition period and good faith compliance standard, CLASS Act provisions, Early Retiree Reinsurance Program (ERRP), retiree only plans, grandfathered plans, grandfathering rules as applied to collectively bargained health plans, coverage of adult children, medical loss ratios (MLRs), limited benefit plans, quality improvement initiatives, meaningful use rules, preventive care, preexisting conditions, annual & lifetime limits, patient protections, claims and appeals procedures, external review, health information technology & electronic health records, health literacy and insurance exchanges, wellness, tax reporting issues, non-discrimination requirements Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 comments on Interim Final Regulations. Health Information Technology for Economic and Clinical Health (HITECH) Act

Client expense: $272,633 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

HR. 1204--Pharmacies Antitrust Carve-out Legislation

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

The Community Pharmacy Fairness Act of 2009, H.R. 1204

Client expense: Not reported · Firm income: $17,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of healthcare reform laws - Executive Branch actions re PL 111-148 and PL 111-152. Repeal Patient Protection and Affordable Health Care Acts (PL 111-148/PL 111-152) - HR 4901, To repeal the Patient Protection and Affordable Care Act; HR 4903, To repeal the Patient Protection and Affordable Care Act; HR 4910, To repeal the Patient Protection and Affordable Care Act and enact the Empowering Patients First Act in order to provide incentives to encourage health insurance coverage; HR 4919, To repeal the Patient Protection and Affordable Care Act; HR 4972, To repeal the Patient Protection and Affordable Care Act; HR 5005, To repeal the Patient Protection and Affordable Care Act; HR 5073, To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 and enact the OPTION Act of 2009; HR 5216, To repeal the Patient Protection and Affordable Care Act; HR 5421, To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, repeal the 7.5 percent threshold on the deduction for medical expenses, provide for increased funding for high-risk pools, allow acquiring health insurance across State lines, and allow for the creation of association health plans; HR 5424, Reform Americans Can Afford Act of 2010 ; HR 5444, Private Option Health Care Act; HR 6355, STAT Act of 2010; S 3147, Patient Choice Restoration Act; S 3152, A bill to repeal the Patient Protection and Affordable Care Act. *Federal Employee Health Benefit Program prescription drugs - HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. *Prescription drug co-pays and formularies - S 1630, Affordable Access to Prescription Medications Act of 2009. *Generic drugs - HR 1706, Protecting Consumer Access to Generic Drugs Act of 2009; HR 4899, Supplemental Appropriations Act, 2010; S 369, Preserve Access to Affordable Generics Act; S 3677, Financial Services and General Government Appropriations Act, 2011. *Antitrust exemption for pharmacies - HR 1204, Community Pharmacy Fairness Act of 2009. *Implementation of healthcare reform legislation; generic biologics - HR 3590, Patient Protection and Affordable Care Act.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Performance Based Pharmacy Reimbursement/Medication Therapy Management proposal; Postal Service - discussions around 5-day mail delivery; Competitive bidding; HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 4489, FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act; S. 369, Preserve Access to Affordable Generics Act; S. 1630, Affordable Access to Prescription Medications Act prescription drug copays and formularies; HR 5597, To establish a Medicare patient IVIG access demonstration project; HR 3790, Repeal of DMEPOS competitive bidding program;

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE

S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2010 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 Under Line 17: We would like to include the Office of National Drug Control Policy (ONDCP) HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act S 80 - Pharmaceutical Market Access Act of 2009 HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA-2010-N-0001) Third Annual Sentinel Initiative Public Workshop (Docket Number: FDA-2010-N-0128) Prescription Drug User Fee Act; Reopening of the Comment Period (Docket Number: FRL-9197-7) EPA Best Management Practices for Unused Pharmaceuticals at Health Care Facilities (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: DEA-338) Schedules of Controlled Substances: Placement of Propofol Into Schedule IV; Proposed Rule (Docket Number: FDA-2010-N-0273) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Quality System Regulations (Docket No. FDA-2010-N-0344) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices and Radiation-Emitting Products (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: FDA-2010-N-0477) Approval Pathway for Biosimilar and Interchangeable Biological Products; Public Hearing; Request for Comments (Docket Number: FDA2010N0486) Safe Use Initiative; Public Workshop; Request for Comments (RIN 0720AB45) DoD Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE: Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals (Docket Number: DEA316N) Procedures for the Surrender of Unwanted Controlled Substances by Ultimate Users; Notice of Meeting (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies FDA Draft Guidance for Industry and Food and Drug Administration Staff on Dear Health Care Provider Letters: Improving Communication of Important Safety Information Concept Standardizing REMS programs, components and development of a potential tiered REMS System Concept 2010 National Drug Control Strategy (ONDCP)

Client expense: $240,240 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE, White House Office

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $525,828 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Election Commission (FEC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Department of Veterans Affairs appropriations and its delivery of benefits and services to veterans, their dependents and survivors: HR 5360, HR 5225, HR 5120, HR 4894, HR 4887, HR 4477, HR 4048, HR 3949, HR 3491, HR 3219, HR 3155, HR 3082, HR 2990, HR 2980, HR 2898, HR 2879, HR 2770, HR 2738, HR 2734, HR 2713, HR 2583, HR 2573, HR 2419, HR 2389, HR 2342, HR 2254, HR 2180, HR 1879, HR 1818, HR 1546, HR 1388, HR 1377, HR 1335, HR 1302, HR 1293, HR 1211, HR 1204, HR 1203, HR 1197, HR 1171, HR 1169, HR 1088, HR 1017, HR 1016, HR 953, HR 952, HR 816, HR 811, HR 775, HR 667, HR 658, HR 612, HR 593, HR 466, HR 456, HR 341, HR 333, HR 303, HR 297, HR 296, HR 295, HR 294, HR 293, H. RES. 261, HR 177, HR 114, HR 108, H. Con. Res 85, HR 32, S 3447, S 3234, S 3148, S 1963, S 1939, S 1779, S 1407, S 1237, S 1204, S 944, S 847, S 821, S 820, S 801, S 728, S 658, S 642, S 597, S. 546, S. 535, S 423, S 407, S 404, S 277, S 252, S 66, S. Con. Res 60, S. Con. Res. 13.

Client expense: $190,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Small Business Administration (SBA), U.S. Postal Service (USPS), Veterans Affairs, Dept of (VA), Veterans Employment & Training Service

HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all"). A. 1796, S. 1679 (Health Care Reform); HR 676/S. 703 (Single payer): PL 111-148; PL 111-152.

Client expense: $998,150 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Performance Based Pharmacy Reimbursement/Medication Therapy Management proposal; Postal Service - discussions around 5-day mail delivery; Competitive bidding; HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 4489, FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act; S. 369, Preserve Access to Affordable Generics Act; S. 1630, Affordable Access to Prescription Medications Act prescription drug copays and formularies; HR 5597, To establish a Medicare patient IVIG access demonstration project; HR 3790, Repeal of DMEPOS competitive bidding program;

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare Demonstration Projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections H.R. 5597 - To Establish a Medciare Patient IVIG Access Demonstration Project; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Healthcare for All America Act; all setions S. 1793 - America's Health Future Act of 2009; all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Healthcare and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $960,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Regulatory Commission, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1204, Community Pharmacy Fairness Act (Weiner) antitrust exemption for pharmacies; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs (cont.) H.R. 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch); H.R. 4899, Supplemental Appropriations Act (Obey) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 1630, Affordable Access to Prescription Medications Act (Rockefeller) prescription drug co-pays and formularies; S. 3677, Financial Services and General Government Appropriations Act (Durbin) generic drugs PHA (Regulatory): Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; and issues relating to access for investigational drugs.

Client expense: $2,330,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

Implementation of healthcare reform legislation; generic biologics Executive Branch actions re PL 111-148 and PL 111-152. *Federal Employee Health Benefit Program prescription drugs - HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. *Prescription drug co-pays and formularies - S 1630, Affordable Access to Prescription Medications Act of 2009. *Generic drugs - HR 1706, Protecting Consumer Access to Generic Drugs Act of 2009; HR 4899, Supplemental Appropriations Act, 2010; S 369, Preserve Access to Affordable Generics Act; S 3677, Financial Services and General Government Appropriations Act, 2011. *Antitrust exemption for pharmacies - HR 1204, Community Pharmacy Fairness Act of 2009.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2009 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting on Opioid REMS (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies DEA National Drug Take-Back Day Concept Standardizing REMS programs, components and development of a potential tiered REMS System

Client expense: $212,859 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

H.R. 1204--Pharmacies Antitrust carve out legislation

Client expense: $430,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

The Community Pharmacy Fairness Act of 2009, H.R. 1204

Client expense: Not reported · Firm income: $17,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Community Pharmacy Fairness Act of 2009 H.R. 1204 Healthy Americans Act H.R. 1321 Emergency Retiree Health Benefits Protection Act H.R. 1322 Long-Term Care Affordability and Security Act of 2009 H.R. 2096 Healthy Families Act H.R. 2460 The Patients Choice Act H.R. 2520 Family Leave Insurance Act of 2009 H.R. 1723 Tax Equity for Health Plan Beneficiaries Act of 2009 H.R. 2625 Prevent application of ERISA preemption to state law causes of action - H.R. 3925 Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 -H.R. 3962/Public Law No: 111-192 Common Sense Health Care Reform and Affordability Act H.R. 4038 American Workers, State, and Business Relief Act H.R. 4213, Unemployment Compensation Extension Act of 2010 Public Law No: 111-205 Health Care Reform regulatory implementation and compliance issues from the Patient Protection and Affordable Care Act (PPACA) Public Law No: 111-148 & the Health Care and Education Reconciliation Act of 2010 (HCERA) Public Law No: 111-152 Senate Healthy Americans Act - S. 391 Long-Term Care Affordability and Security Act of 2009 S. 702 The Patients Choice Act S. 1099 Healthy Families Act S. 1152 Tax Equity for Health Plan Beneficiaries Act of 2009 S. 1153 Confidence in Long-Term Care Insurance Act S. 1177 Patient Centered Outcomes Research Act S. 1213 American Jobs Protection Act S. 3501 American Workers, State, and Business Relief Act H.R. 4213 & substitute amendment Health Care Reform regulatory implementation and compliance issues from the Patient Protection and Affordable Care Act (PPACA) Public Law No: 111-148 & the Health Care and Education Reconciliation Act of 2010 (HCERA) Public Law 111-152 Regulatory communication with covered federal officials on legislative issues Proposed rule on application of ERISA to state/local health reform efforts. COBRA premium subsidy assistance extension American Recovery and Reinvestment Act of 2009 (ARRA) included in the Department of Defense Appropriations Act of 2010 Guidance for and implementation of the Patient Protection and Affordable Care Act (PPACA) & the Health Care and Education Reconciliation Act of 2010 (HCERA) employer responsibility provisions, tax treatment of certain plans, transition period and good faith compliance standard, CLASS Act provisions, Early Retiree Reinsurance Program (ERRP), retiree only plans, grandfathered plans, grandfathering rules as applied to collectively bargained health plans, coverage of adult children, medical loss ratios (MLRs), limited benefit plans, quality improvement initiatives, meaningful use rules, preventive care, preexisting conditions, annual & lifetime limits, patient protections, claims and appeals procedures, external review, health information technology & electronic health records, health literacy and insurance exchanges Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 comments on Interim Final Regulations. Health Information Technology for Economic and Clinical Health (HITECH) Act

Client expense: $199,380 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

H.R. 1204, the Community Pharmacy Fairness Act of 2009; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; working with Senate Committee on Health, Education, Labor and pensions on a potential hearing; working with House Committee on Energy and Commerce (health subcommittee) on a potential hearing; worked with the Senate Committee on Aging to provide information for an ongoing committee investigation of certain retail pharmacy practices; H.R. 5235, the Medicare Access to Diabetes Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; submitted statement for the House Committee on Energy and Commerce hearing on the Part B DME competitive bidding program; H.R. 1586, the Education Jobs and Medicaid funding bill, which included an extension of FMAP and change to the AMP definition and became law on 8/10/2010; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act, includes funding for the Department of Defense and covers the TRICARE pharmacy program; H.R. 3108 and S. 1383, the Medication Therapy Management (MTM) Expanded Benefit Act; worked with Senate offices to gain support for the implemenation of an authpirzed grant program for MTM services; worked with Senate Aging Committee on the issue of nurses as agents in long-term care facilties; H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 (NASPER); H.R. 5809, the Safe Drug Disposal Act and S. 3397, the Secure & Responsible Drug Disposal Act (became law 10-12-10); worked with Congressional offices on the issue of Medicare Part B recoupment by CMS; sough Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); worked with Congressional offices in seeking clarification from the Department of Treasury regarding the new "over the counter" rules with Flexible Spending Accounts (FSA).

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), Treasury, Dept of

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $644,766 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Election Commission (FEC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all"). A. 1796, S. 1679 (Health Care Reform); HR 676/S. 703 (Single payer): PL 111-148; PL 111-152.

Client expense: $638,299 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Department of Veterans Affairs appropriations and its delivery of benefits and services to veterans, their dependents and survivors: HR 5360, HR 5225, HR 5120, HR 4894, HR 4887, HR 4477, HR 4048, HR 3949, HR 3491, HR 3219, HR 3155, HR 3082, HR 2990, HR 2980, HR 2898, HR 2879, HR 2770, HR 2738, HR 2734, HR 2713, HR 2583, HR 2573, HR 2419, HR 2389, HR 2342, HR 2254, HR 2180, HR 1879, HR 1818, HR 1546, HR 1388, HR 1377, HR 1335, HR 1302, HR 1293, HR 1211, HR 1204, HR 1203, HR 1197, HR 1171, HR 1169, HR 1088, HR 1017, HR 1016, HR 953, HR 952, HR 816, HR 811, HR 775, HR 667, HR 658, HR 612, HR 593, HR 466, HR 456, HR 341, HR 333, HR 303, HR 297, HR 296, HR 295, HR 294, HR 293, H. RES. 261, HR 177, HR 114, HR 108, H. Con. Res 85, HR 32, S 3234, S 3148, S 1963, S 1939, S 1779, S 1407, S 1237, S 1204, S 944, S 847, S 821, S 820, S 801, S 728, S 658, S 642, S 597, S. 546, S. 535, S 423, S 407, S 404, S 277, S 252, S 66, S. Con. Res 60, S. Con. Res. 13.

Client expense: $240,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Small Business Administration (SBA), U.S. Postal Service (USPS), Veterans Affairs, Dept of (VA), Veterans Employment & Training Service

Performance Based Pharmacy Reimbursement/Medication Therapy Management proposal; Postal Service - discussions around 5-day mail delivery; competitive bidding; HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 4489, FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act; S. 369, Preserve Access to Affordable Generics Act; S. 1630, Affordable Access to Prescription Medications Act prescription drug copays and formularies; HR 5597, To establish a Medicare patient IVIG access demonstration project; HR 3790, Repeal of DMEPOS competitive bidding program; HR 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 / PL 111-192

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to corporate business model, specifically anti-PBM legislation and disclosure of proprietary pricing and contracting information and improvements to health care delivery and cost containment. Restrictions on PBM cost saving tools like mail order, generics and discount programs. Changes to PBM audit of suspect network pharmacies. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009; HR 5234 PBM Audit Reform and Transparency Act of 2010. Issues relating to a proposed anti-trust exemption for certain pharmacies, healthcare competition and the CVS Caremark business model. HR 1204 - Community Pharmacy Fairness Act of 2009

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1204, Community Pharmacy Fairness Act (Weiner) antitrust exemption for pharmacies; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; (cont.) H.R. 3590, Patient Protection and Affordable Care Act (Reid) generic biologics; H.R. 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch); H.R. 4899, Supplemental Appropriations Act (Obey) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 1630, Affordable Access to Prescription Medications Act (Rockefeller) prescription drug co-pays and formularies PHA (Regulatory): Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; and issues relating to access for investigational drugs.

Client expense: $2,290,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

The Community Pharmacy Fairness Act of 2009, H.R. 1204

Client expense: Not reported · Firm income: $21,250

Government targets: HOUSE OF REPRESENTATIVES, SENATE

health care ceform, health care regulations, Medicare Part D, proposed antitrust exemptions for certain pharmacists, IVIG payments, Medicare Demonstration Projects for durable medical equipment, importation of prescription drugs, home infusion, disclosure of PBM information, changes to drug benefits offered under the FEHBP and increasing healthcare value. H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Health Care for America Act; all sections S 1793 - America's Healthy Future Act of 2009; all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $600,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies

Client expense: $35,673 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1204, Community Pharmacy Fairness Act of 2009

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $551,889 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Election Commission (FEC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $551,889 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Election Commission (FEC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1204 - The Community Pharmacy Fairness Act of 2009 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 SRes 539 - A resolution designating May 24, 2010, as "Prescription Drug Disposal Awareness Day S 256 - Combat Methamphetamine Enhancement Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Drug Safety and Risk Management Advisory Committee; Notice of Meeting (Docket Number: FDA-2009-N-0247) FDA Transparency Initiative: Draft Proposals for Public Comment Regarding Disclosure Policies of the U.S. Food and Drug Administration; Availability (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA2009D0461) FDA Draft Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all pharmacy-based communications (Docket Number: FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number: FDA-2010-N-0001) Pharmaceutical Supply Chain; Public Workshop (Docket Number: DEA-218I) Electronic Prescriptions for Controlled Substances; Final Rule (Docket Number: FDA-2009-N-0582) Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner (Docket Number: FDA-2010-N-0136) Request for Comment on Implementation of the Family Smoking Prevention and Tobacco Control Act (Docket Number: DEA-328P) Implementation of the Methamphetamine Production Prevention Act of 2008 (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting (Opioid REMS) (Docket Number: FDA-2010-N-0284, FDA-2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting (Docket Number: FDA-2009-D-0001) Guidance for Industry on Standards for Securing the Drug Supply Chain--Standardized Numerical Identification for Prescription Drug Packages; Availability ONDCPs 2010 National Drug Control Policy FDA Safe Use Initiative Concept - Reauthorization of Prescription Drug User Fee Act Concept - DEA Agent of the Prescriber Concept - Oppose Liberalizing Prescription Drug Importation

Client expense: $151,510 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Community Pharmacy Fairness Act of 2009 H.R. 1204 Healthy Americans Act H.R. 1321A Emergency Retiree Health Benefits Protection Act H.R. 1322 Family Leave Insurance Act of 2009 H.R. 1723 Long-Term Care Affordability and Security Act of 2009 H.R. 2096 Healthy Families Act H.R. 2460 The Patients Choice Act H.R. 2520 Tax Equity for Health Plan Beneficiaries Act of 2009 H.R. 2625 Health Care Reform regulatory implementation and compliance issues from the Patient Protection and Affordable Care Act (PPACA) Public Law No: 111-148 & the Health Care and Education Reconciliation Act of 2010 (HCERA) Public Law No: 111-152 Prevent application of ERISA preemption to state law causes of action - H.R. 3925 Affordable Health Care for America Act H.R. 3962 Common Sense Health Care Reform and Affordability Act H.R. 4038 American Workers, State, and Business Relief Act H.R. 4213, & substitute amendment Jobs for Main Street Act House Amendment to the Senate Amendment to H.R. 2847 Senate Healthy Americans Act - S. 391 Long-Term Care Affordability and Security Act of 2009 S. 702 The Patients Choice Act S. 1099 Healthy Families Act S. 1152 Tax Equity for Health Plan Beneficiaries Act of 2009 S. 1153 Confidence in Long-Term Care Insurance Act S. 1177 Patient Centered Outcomes Research Act S. 1213 The COBRA Subsidy Extension and Enhancement Act S. 2730 Health Care Reform regulatory implementation and compliance issues from the Patient Protection and Affordable Care Act (PPACA) Public Law No: 111-148 & the Health Care and Education Reconciliation Act of 2010 (HCERA) Public Law 111-152 American Workers, State, and Business Relief Act H.R. 4213 & substitute amendment Temporary Extension Act of 2010 H.R. 4691 Public Law No: 111-144 COBRA Subsidy Program extension Continuing Extension Act H.R. 4851: short-term COBRA extension The Democratic Substitute/Revised Version to the Continuing Extension Act H.R. 4851 Regulatory communication with covered federal officials on legislative issues Proposed rule on application of ERISA to state/local health reform efforts. COBRA premium subsidy assistance extension American Recovery and Reinvestment Act of 2009 (ARRA) included in the Department of Defense Appropriations Act of 2010. Guidance for and implementation of the Patient Protection and Affordable Care Act (PPACA) & the Health Care and Education Reconciliation Act of 2010 (HCERA) employer responsibility provisions, tax treatment of certain plans, transition period and good faith compliance standard, CLASS Act provisions, Early Retiree Reinsurance Program (ERRP), grandfathered plans, grandfathering rules as applied to collectively bargained health plans, coverage of adult children, medical loss ratios (MLRs), quality improvement initiatives, retiree-only plans, preexisting conditions, annual & lifetime limits, patient protections. Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 comments on Interim Final Regulations. Genetic Information Nondiscrimination Act (GINA) of 2008

Client expense: $222,965 · Firm income: Not reported

Government targets: Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), Pension Benefit Guaranty Corporation (PBGC), SENATE, Treasury, Dept of, Vice President of the U.S., White House Office

H.R. 1204--Pharmacies Antitrust carve out legislation

Client expense: $410,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Labor Issues related to workforce development & retention. Issues relating to a proposed anti-trust exemption for certain pharmacies, healthcare competition and the CVS Caremark business model. HR 1204 - Community Pharmacy Fairness Act of 2009

Client expense: $2,250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all"). A. 1796, S. 1679 (Health Care Reform); HR 676/S. 703 (Single payer): PL 111-148; PL 111-152.

Client expense: $1,568,045 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Department of Veterans Affairs appropriations and its delivery of benefits and services to veterans, their dependents and survivors: HR 5360, HR 4894, HR 4887, HR 4477, HR 4048, HR 3949, HR 3491, HR 3155, HR 3082, HR 2990, HR 2980, HR 2898, HR 2879, HR 2770, HR 2738, HR 2734, HR 2713, HR 2583, HR 2573, HR 2419, HR 2389, HR 2342, HR 2254, HR 2180, HR 1879, HR 1818, HR 1546, HR 1388, HR 1377, HR 1335, HR 1302, HR 1293, HR 1211, HR 1204, HR 1203, HR 1197, HR 1171, HR 1169, HR 1088, HR 1017, HR 1016, HR 953, HR 952, HR 816, HR 811, HR 775, HR 667, HR 658, HR 612, HR 593, HR 466, HR 456, HR 341, HR 333, HR 303, HR 297, HR 296, HR 295, HR 294, HR 293, H.RES. 261, HR 177, HR 114, HR 108, H.Con. Res 85, HR 32, S 3148, S 1963, S 1939, S 1779, S 1407, S 1204, S 944, S 847, S 821, S 820, S 801, S 728, S 658, S 642, S 597, S. 546, S. 535, S 423, S 407, S 404, S 277, S 252, S 66, S.Con.Res. 13.

Client expense: $190,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Small Business Administration (SBA), U.S. Postal Service (USPS), Veterans Affairs, Dept of (VA), Veterans Employment & Training Service

*Antitrust exemption for pharmacies - HR 1204, Community Pharmacy Fairness Act of 2009. *Generic drugs - HR 1706, Protecting Consumer Access to Generic Drugs Act of 2009; HR 4899, Supplemental Appropriations Act, 2010; S 369, Preserve Access to Affordable Generics Act. *Generic biologics - HR 3590, Patient Protection and Affordable Care Act. *Federal Employee Health Benefit Program prescription drugs - HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. *Prescription drug co-pays and formularies - S 1630, Affordable Access to Prescription Medications Act of 2009.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

Support legislation (HR 1204) to allow independent pharmacists to collectively negotiate contracts with prescrption drug plans and health insurance plans. Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health care plans; and create a fund for prescription medicines for low-income individuals.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE